EUVIMEDEUVIMED entdecken
Crossref

Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply

Akshay Desai, Andrea Havasi, Manish Saxena

JAMA · 04.11.2025 · 334 (17) · 1559

DOI: 10.1001/jama.2025.13329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 04.11.2025. Verfasst von Akshay Desai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Alnylam Pharmaceuticals, Cambridge, Massachusetts.
  • Barts Health NHS Trust, Queen Mary University of London, London, United Kingdom.

Zitieren

APA

Desai, A., Havasi, A., & Saxena, M. (2025). Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply. JAMA, 334(17), 1559. https://doi.org/10.1001/jama.2025.13329

Vancouver

Desai A, Havasi A, Saxena M. Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply. JAMA. 2025;334(17):1559. doi:10.1001/jama.2025.13329

BibTeX
@article{Desai2025,
  author = {Desai, Akshay and Havasi, Andrea and Saxena, Manish},
  title = {Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply},
  journal = {JAMA},
  year = {2025},
  volume = {334},
  number = {17},
  pages = {1559},
  doi = {10.1001/jama.2025.13329}
}
Kostenlos starten →